Immuneering Corp (IMRX)
1.39
+0.01
(+0.72%)
USD |
NASDAQ |
May 31, 16:00
1.39
0.00 (0.00%)
After-Hours: 20:00
Immuneering Total Liabilities (Quarterly): 9.260M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.260M |
December 31, 2023 | 12.01M |
September 30, 2023 | 9.863M |
June 30, 2023 | 9.791M |
March 31, 2023 | 9.907M |
December 31, 2022 | 12.52M |
September 30, 2022 | 11.80M |
Date | Value |
---|---|
June 30, 2022 | 8.455M |
March 31, 2022 | 8.391M |
December 31, 2021 | 10.72M |
September 30, 2021 | 5.749M |
June 30, 2021 | 88.23M |
March 31, 2021 | 3.282M |
December 31, 2020 | 60.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.282M
Minimum
Mar 2021
88.23M
Maximum
Jun 2021
18.63M
Average
9.885M
Median
Total Liabilities (Quarterly) Benchmarks
Geron Corp | 137.21M |
SELLAS Life Sciences Group Inc | 14.75M |
Elicio Therapeutics Inc | 19.61M |
ADMA Biologics Inc | 197.17M |
Outlook Therapeutics Inc | 193.26M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 87.98M |
Shareholders Equity (Quarterly) | 78.72M |